- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 24.09. | InnovAge Holding Corp. - 8-K, Current Report | 1 | SEC Filings | ||
| 23.09. | InnovAge (INNV) Shares Tumble 9% After Hours: Here's Why | 1 | Benzinga.com | ||
| 23.09. | InnovAge prices 10M share secondary offering at $9.25 | 2 | Seeking Alpha | ||
| INNOVAGE Aktie jetzt für 0€ handeln | |||||
| 23.09. | InnovAge stockholders price 10M share offering at $9.25 | 1 | Investing.com | ||
| 23.09. | InnovAge Announces Pricing of Secondary Offering of Common Stock by Selling Stockholders | 1 | GlobeNewswire (USA) | ||
| 22.09. | InnovAge Aktie bricht nach Ankündigung einer Sekundärplatzierung ein | 1 | Investing.com Deutsch | ||
| 22.09. | InnovAge Aktie bricht nach angekündigter Aktienplatzierung durch Großinvestoren ein | 2 | Investing.com Deutsch | ||
| 22.09. | InnovAge Announces Launch of Proposed Secondary Offering of Common Stock by Selling Stockholders | 3 | GlobeNewswire (USA) | ||
| 11.09. | InnovAge (INNV) Reaches a 9.6% Adjusted EBITDA Margin. Can the PACE Recovery Last? | 1 | Insider Monkey | ||
| 09.09. | InnovAge auf Wells Fargo Konferenz: Wachstumsplan trifft auf Margendisziplin | 2 | Investing.com Deutsch | ||
| 09.09. | KeyBanc raises Innovage stock price target on strong results | 1 | Investing.com | ||
| 09.09. | InnovAge Aktie springt nach starkem Ausblick und Turnaround um 14 % | 1 | Investing.com Deutsch | ||
| 09.09. | InnovAge Holding (INNV) Stock Jumps Over 10% After-Hours: Why is it Moving? | 1 | Benzinga.com | ||
| 09.09. | InnovAge forecasts $1.05B-$1.085B revenue and $105M-$115M adjusted EBITDA for fiscal 2027 as it targets 5%-7.5% census growth | 2 | Seeking Alpha | ||
| 09.09. | InnovAge Holding Corp. - 10-K, Annual Report | - | SEC Filings | ||
| 09.09. | InnovAge Holding Reports Q4 2026 Results: Full Earnings Call Transcript | 2 | Benzinga.com | ||
| 08.09. | InnovAge GAAP EPS of $0.06 misses by $0.01, revenue of $261.95M beats by $23.68M | 2 | Seeking Alpha | ||
| 08.09. | InnovAge Announces Financial Results for the Fourth Quarter and Fiscal Year Ended June 30, 2026 | 158 | GlobeNewswire (Europe) | DENVER, Sept. 08, 2026 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge" or the "Company") (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly... ► Artikel lesen | |
| 08.09. | InnovAge Holding Corp. - 8-K, Current Report | 1 | SEC Filings | ||
| 21.08. | Innovage: KeyBanc hebt Rating nach erfolgreichem Turnaround an | 1 | Investing.com Deutsch |
1 2 Weiter >>
29 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| HIMS & HERS HEALTH | 26,040 | -0,38 % | Novo Nordisk, Eli Lilly oder Hims & Hers: Welche Abnehmspritzen-Aktie im Trend-Check vorne liegt - Jetzt lesen! | ||
| AUTONOMIX MEDICAL | 2,140 | -0,47 % | Autonomix Medical, Inc.: Autonomix Reports Positive FDA Feedback Supporting 510(k) Pathway to U.S. Clearance | FDA pre-submission feedback supports a Class II strategy, leveraging substantial equivalence to a previously cleared device, positioning the Company for potential initial U.S. clearance of its standalone... ► Artikel lesen | |
| EXAGEN | 6,950 | -7,95 % | Exagen Inc.: Exagen to Announce Third Quarter Financial Results on November 10, 2026 | ||
| ALIGNMENT HEALTHCARE | 8,165 | 0,00 % | Needham initiates Alignment Healthcare stock rating at Hold | ||
| HEARTFLOW | 59,12 | +0,03 % | Biotech Stocks At 52-Week Highs - Vaxcyte +31% On Phase 3 Results, InfuSystem, Illumina +7%, Charles River Laboratories +7%, HeartFlow +5% | SAN DIEGO (dpa-AFX) - The following biotech stocks reached a 52-week high on October 5, 2026, driven by key catalysts such as encouraging clinical research data.Vaxcyte Inc. (PCVX)Vaxcyte is... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 59,48 | 0,00 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 13,395 | +0,04 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| PROGYNY | 27,870 | 0,00 % | Progyny, Inc.: New Progyny Study Examines Persistent Racial and Ethnic Differences in Fertility Treatment Initiation Despite Access to Benefits | ||
| BILLIONTOONE | 113,94 | -0,05 % | BillionToOne, Inc.: BillionToOne's Tissue-Free Northstar Response Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds | MENLO PARK, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| BETA BIONICS | 17,810 | 0,00 % | Truist reiterates Buy on Beta Bionics stock, $28 target on MINT | ||
| ADAPTHEALTH | 6,030 | 0,00 % | Morning Market Movers: Ameresco, Inno Holdings, AdaptHealth, Ibotta See Big Swings | OTTAWA (dpa-AFX) - At 7:50 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| KESTRA MEDICAL TECHNOLOGIES | 29,870 | 0,00 % | Kestra Medical Technologies, Ltd.: Kestra Medical Technologies Reports First Quarter Fiscal 2027 Financial Results | KIRKLAND, Wash., Sept. 14, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today reported financial results... ► Artikel lesen | |
| GENEDX | 64,61 | -0,12 % | GeneDx plans to add long-read genome sequencing to portfolio | ||
| BASEL MEDICAL GROUP | 4,625 | 0,00 % | Morning Market Movers: Aehr Test Systems, Pentair, NextCure, Basel Medical Group See Big Swings | BEIJING (dpa-AFX) - At 8:30 a.m. ET on Wednesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen |
INNOVAGE HOLDING CORP gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 9,100 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu INNOVAGE HOLDING CORP finden Sie auf Wallstreet Online.